v3.25.4

Stock Compensation | 12 Months Ended
--- | ---
Dec. 31, 2025
Stock Compensation [Abstract] |
STOCK COMPENSATION | 6. STOCK COMPENSATION Stock Incentive Plans In 2018, the Company adopted the 2018 Stock Incentive Plan (the “2018 Plan”) for employees, consultants, and directors. The 2018 Plan, which is administered by the Company’s Board of Directors, permits the Company to grant incentive and nonqualified stock options for the purchase of common stock, and restricted stock awards. The maximum number of shares of common stock reserved for issuance under the 2018 Plan is 20. At December 31, 2025 there were 9 shares of common stock available for grant under the 2018 Plan. On July 6, 2021, the Company’s Board of Directors and stockholders approved and adopted the Bluejay Diagnostics, Inc. 2021 Stock Plan (the “2021 Plan”). A total of 61 shares of common stock were approved to be initially reserved for issuance under the 2021 Stock Plan. At December 31, 2025 there were 25 shares of common stock available for grant under the 2021 Plan. Stock Award Activity The following table summarizes the status of the Company’s non-vested restricted stock awards for years ended December 31, 2025:
|  | Non-vested Restricted Stock Awards |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value |
Outstanding at December 31, 2024 |  |  | - |  |  | $ | 41,280 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (- | ) |  |  | 41,280 |
Cancelled / forfeited |  |  | - |  |  |  | - |
Outstanding at December 31, 2025 |  |  | - |  |  | $ | - |
Stock Option Plan Summary The following is a summary of stock option activity for the year ended December 31, 2025:
|  | Number of Stock Options |  |  | Weighted Average Exercise Price Per Share |  |  | Weighted Average Remaining Contractual Life in Years |  |  | Aggregate Intrinsic Value |
Outstanding at December 31, 2024 |  |  | 18 |  |  | $ | 59,864 |  |  |  | 5.8 |  |  | $ | - |
Granted |  |  | - |  |  |  | - |  |  |  |  |  |  |  | - |
Exercised |  |  | - |  |  |  | - |  |  |  |  |  |  |  | - |
Cancelled / forfeited |  |  | (13 | ) |  |  | 75,052 |  |  |  |  |  |  |  | - |
Outstanding at December 31, 2025 |  |  | 5 |  |  | $ | 20,376 |  |  |  | 3.0 |  |  | $ | - |
Exercisable at December 31, 2025 |  |  | 5 |  |  | $ | 20,376 |  |  |  | 3.0 |  |  | $ | - |
Stock-Based Compensation Expense For the years ended December 31, 2025 and 2024, the Company recorded stock-based compensation expense as follows:
|  | Year ended December 31, |
|  | 2025 |  |  | 2024 |
Research and development |  | $ | (193 | ) |  | $ | 16,648 |
General and administrative |  |  | 199 |  |  |  | 3,446 |
Marketing and business development |  |  | - |  |  |  | - |
Total stock-based compensation |  | $ | 6 |  |  | $ | 20,094 |
At December 31, 2025, there was no unrecognized compensation expense related to non-vested stock option awards and non-vested restricted stock awards.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/718/tableOfContent Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration